A new analytic tool for interrupted times series analysis to assess the impact of FDA regulatory actions

被引：0
|
作者：
Lu, Christine Y. [1 ]
Hou, Laura [1 ]
Kolonoski, Joy [1 ,2 ]
Petrone, Andrew B. [1 ]
Zhang, Fang [1 ]
Corey, Catherine [3 ]
Huang, Ting Ying [1 ]
Bradley, Marie C. [4 ]
机构：
[1] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[3] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
[4] US FDA, Div Epidemiol, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 50 条
  • [1] A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions
    Lu, Christine Y.
    Hou, Laura
    Kolonoski, Joy
    Petrone, Andrew B.
    Zhang, Fang
    Corey, Catherine
    Huang, Ting-Ying
    Bradley, Marie C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (03) : 298 - 311
  • [2] Clinical Impact of an Analytic Tool for Predicting the Fall Risk in Inpatients: Controlled Interrupted Time Series
    Cho, Insook
    Jin, In Sun
    Park, Hyunchul
    Dykes, Patricia C.
    [J]. JMIR MEDICAL INFORMATICS, 2021, 9 (11)
  • [3] DIOGENES SHEDS NEW LIGHT ON FDA REGULATORY ACTIONS
    SNOW, B
    [J]. DATABASE, 1988, 11 (02): : 72 - 80
  • [4] A new analytic tool developed in the Sentinel System to assess adherence to FDA's safe use recommendations
    Cocoros, Noelle M.
    Wagner, Anita
    Haynes, Kevin
    Petrone, Andrew B.
    Fazio-Eynullayeva, Elnara
    Ding, Yulan
    Izem, Rima
    Lee, Joo-Yeon
    Major, Jacqueline M.
    Nguyen, Michael
    Ju, Jing
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 514 - 514
  • [5] A critical review of methods to evaluate the impact of FDA regulatory actions
    Briesacher, Becky A.
    Soumerai, Stephen B.
    Zhang, Fang
    Toh, Sengwee
    Andrade, Susan E.
    Wagner, Joann L.
    Shoaibi, Azadeh
    Gurwitz, Jerry H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (09) : 986 - 994
  • [6] Critically reviewing impact of regulatory actions, not just FDA's
    Mol, Peter G. M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 105 - 105
  • [7] The impact of war on trade: An interrupted times-series study
    Anderton, CH
    Carter, JR
    [J]. JOURNAL OF PEACE RESEARCH, 2001, 38 (04) : 445 - 457
  • [8] The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis
    Althunian, Turki A.
    Alomran, Maha, I
    Alsagri, Ghada M.
    Alrasheed, Meshael M.
    Alshammari, Thamir M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (05) : 577 - 582
  • [9] Critically reviewing impact of regulatory actions, not just FDA's Response
    Briesacher, Becky A.
    Soumerai, Stephen B.
    Zhang, Fang
    Toh, Sengwee
    Andrade, Susan E.
    Wagner, Joann L.
    Shoaibi, Azadeh
    Gurwitz, Jerry H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 106 - 106
  • [10] The impact of regulatory restrictions on the use of pregabalin: An interrupted time-series
    Althunian, Turki A.
    Alomran, Maha
    Alsagri, Ghada
    Alrasheed, Meshael
    Alshammari, Thamir M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 360 - 360
12345